Mutational Profile of Metastatic Breast Cancer Tissue in Patients Treated with Exemestane Plus Everolimus

BACKGROUND: Everolimus has been shown to overcome endocrine resistance in hormone receptor positive advanced breast cancer patients. Predictive biomarkers of everolimus efficacy have been investigated in primary breast cancer tissue without finding univocal results. The goal of this study was to inv...

Descripción completa

Detalles Bibliográficos
Autores principales: Omarini, Claudia, Filieri, Maria Elisabetta, Bettelli, Stefania, Manfredini, Samantha, Kaleci, Shaniko, Caprera, Cecilia, Nasso, Cecilia, Barbolini, Monica, Guaitoli, Giorgia, Moscetti, Luca, Maiorana, Antonino, Conte, Pier Franco, Cascinu, Stefano, Piacentini, Federico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081542/
https://www.ncbi.nlm.nih.gov/pubmed/30140695
http://dx.doi.org/10.1155/2018/3756981

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6081542/
https://www.ncbi.nlm.nih.gov/pubmed/30140695
http://dx.doi.org/10.1155/2018/3756981

Ejemplares similares